LivaNova (FRA:LIA) Other Current Liabilities: €451 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:LIA LivaNova PLC FRA:LIA
74 GF Score
Price €73.00
GF Value €57.76
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is LivaNova Other Current Liabilities?

LivaNova FRA:LIA +2.82% 74 Other Current Liabilities is €451 Mil as of Mar. 2026. GuruFocus rates FRA:LIA with a GF Score™ of 74/100 and a GF Value™ of €57.76 (Modestly Overvalued). The stock has 7 warning signs investors should review.

LivaNova's other current liabilities for the quarter that ended in Mar. 2026 was €451 Mil.

LivaNova's quarterly other current liabilities increased from Sep. 2025 (€466 Mil) to Dec. 2025 (€476 Mil) but then declined from Dec. 2025 (€476 Mil) to Mar. 2026 (€451 Mil).

LivaNova's annual other current liabilities declined from Dec. 2023 (€104 Mil) to Dec. 2024 (€98 Mil) but then increased from Dec. 2024 (€98 Mil) to Dec. 2025 (€476 Mil).

LivaNova Other Current Liabilities Related Terms

LivaNova Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for LivaNova's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LivaNova Other Current Liabilities Chart

LivaNova Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 263.51 103.12 104.29 98.47 475.81

LivaNova Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 400.96 456.51 466.24 475.81 450.95
FRA:LIA
74GF Score
LivaNova PLC FRA:LIA
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LivaNova Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of €451 Mil mean?
LivaNova (FRA:LIA) has a Other Current Liabilities of €451 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on LivaNova.
Is LivaNova's Other Current Liabilities too high?
LivaNova's current Other Current Liabilities is €451 Mil. Overall, LivaNova has a GF Score™ of 74/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does LivaNova's Other Current Liabilities compare to IRTC and HAE?
LivaNova's Other Current Liabilities of €451 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Medical Devices & Instruments company?
A good Other Current Liabilities depends on the Medical Devices & Instruments industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on LivaNova. LivaNova's current Other Current Liabilities is €451 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LivaNova stock overvalued right now?
Based on GuruFocus' analysis, LivaNova (FRA:LIA) is currently considered Modestly Overvalued. The stock's GF Value™ is €57.76, compared to a current price of €73.00 — trading 26.4% above its estimated fair value. The current Other Current Liabilities is €451 Mil. LivaNova's overall GF Score™ is 74/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For LivaNova (FRA:LIA), the current Other Current Liabilities is €451 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is LivaNova (FRA:LIA) Overvalued in 2026?

Based on GuruFocus' analysis, LivaNova stock appears to be overvalued. The current stock price of €73.00 is trading 26.4% above its estimated GF Value™ of €57.76. GuruFocus considers LivaNova to be Modestly Overvalued.

Key valuation signals for FRA:LIA:

  • Other Current Liabilities: €451 Mil
  • GF Value™: €57.76 vs. price of €73.00 (26.4% above fair value)
  • GF Score™: 74/100 with 7 warning signs

No single metric tells the full story. See the FRA:LIA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

LivaNova Business Description

Other Exchanges LIVN:USA
Address 20 Eastbourne Terrace, London, GBR, W2 6LG
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
74GF Score

Get the complete analysis for FRA:LIA

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€73.00
Price
€57.76
GF Value